Armodafinil (Nuvigil)

What it treats

Armodafinil is approved by the U.S. Food and Drug Administration for the same indications as modafinil:

• Excessive daytime sleepiness in narcolepsy.
• Shift-work sleep disorder.
• Residual excessive sleepiness in treated obstructive sleep apnea.

The clinical decision between armodafinil and modafinil comes down to duration of effect and formulary/cost considerations. Armodafinil's longer half-life makes single-dose coverage more consistent for many patients.

How it works

Armodafinil promotes wakefulness through mechanisms that aren't fully mapped. Current understanding is that it is a modest dopamine reuptake inhibitor at the dopamine transporter, with downstream effects on histamine, orexin, and norepinephrine wake-promoting circuits. That combined effect raises alertness without producing the same peripheral or euphoric activation as traditional stimulants.

Because armodafinil is only the R-enantiomer of modafinil, a given dose stays at effective plasma levels longer than the same dose of racemic modafinil, since the R-form is metabolized more slowly than the S-form.

Receptor mechanism (detail)

Armodafinil is a weak dopamine transporter (DAT) inhibitor with downstream effects on the histamine, orexin, and norepinephrine systems that maintain wakefulness. Structurally, it's the (R)-(-)-enantiomer of modafinil. Its half-life (about 15 hours) is longer than that of racemic modafinil's mean, because the S-enantiomer in racemic modafinil is cleared faster. That's why armodafinil often gives a smoother, longer-lasting effect from once-daily dosing.

Potency and typical dosing pattern

Ranges are typical framework only, not a prescription for any individual.

Narcolepsy and OSA: 150 mg to 250 mg once daily in the morning. Shift-work sleep disorder: 150 mg taken about an hour before the shift starts. 150 mg is often enough; 250 mg is used when needed and tolerated.

Half-life is around 15 hours.

Safety monitoring

• Blood pressure and heart rate at baseline and periodically.
• Serious skin reactions. Stevens-Johnson syndrome and toxic epidermal necrolysis have been reported, rarely. New rash, especially with fever or mucous membrane involvement, is a reason to stop and seek urgent care.
• Psychiatric symptoms. Anxiety, agitation, mania, hallucinations, or suicidal thoughts can occur.
• Drug interactions. Armodafinil induces CYP3A4 and reduces oral contraceptive effectiveness.
• Schedule IV controlled substance.
• Contraception. Reduced oral contraceptive effectiveness during use and for 1 month after stopping.

What to expect

Common side effects

• Headache, the most common.
• Nausea.
• Dizziness.
• Trouble sleeping, especially with later dosing.
• Reduced appetite.
• Dry mouth.
• Nervousness or anxiety.

Serious side effects and warnings

• Serious skin reactions. Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS. Rare. New rash, especially with fever or mucous membrane involvement, means stop and seek urgent care.
• Psychiatric symptoms. New anxiety, mania, hallucinations, aggression, or suicidal thoughts need prescriber contact.
• Cardiovascular events. Modest blood pressure rise. Chest pain, arrhythmia, or signs of a cardiovascular event need immediate evaluation.
• Angioedema and anaphylaxis, rare.
• Contraceptive failure as with modafinil.

Sexual side effects

Armodafinil isn't a notable cause of sexual side effects. If a change occurs, mention it to a prescriber.

Weight, appetite, and sleep

Reduced appetite is common but usually modest. Some weight loss is possible. Sleep timing matters: the long half-life makes later dosing likely to interfere with nighttime sleep.

Starting and dosing basics

This section is general background, not a dosing instruction for any individual. The right dose is a decision for a prescriber.

Armodafinil comes as tablets in 50, 150, 200, and 250 mg strengths. Taken once daily in the morning, or an hour before a night shift.

Missed doses and interactions

If a morning dose is missed and it's still early, take it. If it's late, skip and resume the next day.

Armodafinil, like modafinil, induces CYP3A4 and reduces:

• Oral contraceptives. Use a backup non-hormonal method during and for 1 month after stopping.
• Cyclosporine, some HIV medications, some anticonvulsants.

It also modestly inhibits CYP2C19, raising levels of diazepam, phenytoin, and propranolol.

Give every prescriber and pharmacist the full medication list.

Stopping and tapering

Armodafinil doesn't require a formal taper. Underlying sleepiness will likely return if not otherwise treated.

Pregnancy and breastfeeding

Armodafinil use in pregnancy is generally avoided when possible. Pregnancy registry data suggest a signal for intrauterine growth restriction and possible birth defects. Anyone pregnant, planning a pregnancy, or breastfeeding should discuss this with the prescriber, ideally before conception. Contraceptive planning matters given the interaction with hormonal contraceptives.

Cost and generic availability

Armodafinil is available as a generic and is much less expensive than brand-name Nuvigil. Insurance coverage is common for the approved indications; off-label use is often not covered.

Common questions

How is armodafinil different from modafinil? It's the R-enantiomer of modafinil, which is the longer-lasting half of the molecule. Same pharmacology, longer half-life, tends to produce smoother once-daily coverage.

Is it more effective? The efficacy is broadly similar. The main difference is pharmacokinetic: steadier plasma levels through the day with a single dose.

Can I take my birth control pill while on armodafinil? It reduces oral contraceptive effectiveness. Use a non-hormonal backup method during use and for 1 month after stopping.

Is it addictive? Its misuse liability is lower than amphetamines, which is why it's Schedule IV. Some potential exists.

What should I do about a new rash? Stop the medication and contact the prescriber urgently.

Questions to ask your prescriber

• Why armodafinil over modafinil for me?
• What are we hoping this treats, and how will we know it's working?
• Which of my other medications does armodafinil interact with?
• If I'm on hormonal contraception, what should I use for backup?
• If I need to stop it, is a taper needed?

Sources

This guide draws on current prescribing information and public health references and current as of June 8, 2026. It is reviewed for clinical accuracy and updated as guidance changes.

• U.S. Food and Drug Administration. Armodafinil (Nuvigil) prescribing information.
• MedlinePlus, U.S. National Library of Medicine. Armodafinil.
• American Academy of Sleep Medicine. Clinical Practice Guideline for the Treatment of Central Disorders of Hypersomnolence.
• National Institute of Neurological Disorders and Stroke. Narcolepsy information page.